Christopher Herbst
Overview
Explore the profile of Christopher Herbst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onvlee O, Kok M, Buchan J, Dieleman M, Hamza M, Herbst C
Int J Health Policy Manag
. 2024 Apr;
12:7306.
PMID: 38618826
Background: Conflict has devastating effects on health systems, especially on healthcare workers (HCWs) working in under-resourced and hostile environments. However, little evidence is available on how policy-makers, often together with...
2.
Allen L, Wild C, Loffreda G, Kak M, Aghilla M, Emahbes T, et al.
PLOS Glob Public Health
. 2023 Mar;
2(11):e0000615.
PMID: 36962549
The Libyan Ministry of Health is keen to understand how it can introduce policies to protect its population from non-communicable diseases (NCDs). We aimed to perform an implementation research assessment...
3.
Herbst C, Harshyne L, Igyarto B
Front Immunol
. 2022 Nov;
13:1053582.
PMID: 36389660
Dendritic cells (DCs) are required for the initiation of the adaptive immune response. Their ability to acquire antigens in the periphery is a critical step in this process. DCs express...
4.
Qin Z, Bouteau A, Herbst C, Igyarto B
PLoS Pathog
. 2022 Sep;
18(9):e1010830.
PMID: 36054264
Hundreds of millions of SARS-CoV-2 mRNA-LNP vaccine doses have already been administered to humans. However, we lack a comprehensive understanding of the immune effects of this platform. The mRNA-LNP-based SARS-CoV-2...
5.
Qin Z, Bouteau A, Herbst C, Igyarto B
bioRxiv
. 2022 Aug;
PMID: 36032972
Authors Summary: We bring experimental evidence that pre-exposure to mRNA-LNPs or its LNP component affects innate and adaptive immune responses. Pre-exposure to mRNA-LNPs led to long-term inhibition of the adaptive...
6.
Almoteiry K, Alharf A, Al Hammad B, Aljuffali I, Al-Azemi N, Al-Ghaith T, et al.
Bull World Health Organ
. 2022 Aug;
100(8):511-519.
PMID: 35923275
Medicines are at the core of every health system. The World Health Organization recommends countries develop national medicines policies that guide production, procurement, prescription and provision of medicines so that...
7.
Ndeupen S, Bouteau A, Herbst C, Qin Z, Jacobsen S, Powers N, et al.
PLoS Pathog
. 2022 Jan;
18(1):e1010255.
PMID: 35073387
Nucleoside modified mRNA combined with Acuitas Therapeutics' lipid nanoparticles (LNPs) has been shown to support robust humoral immune responses in many preclinical animal vaccine studies and later in humans with...
8.
Schultze-Berndt A, Kuhnisch J, Herbst C, Seidel F, Al-Wakeel-Marquard N, Dartsch J, et al.
Front Pediatr
. 2021 Sep;
9:722926.
PMID: 34540771
Left ventricular noncompaction cardiomyopathy (LVNC CMP) is a genetic cardiomyopathy. Genotype-phenotype correlation and clinical outcome of genetic variants in pediatric and adult LVNC CMP patients are still unclear. The retrospective...
9.
Ndeupen S, Bouteau A, Herbst C, Qin Z, Hutchins Z, Kurup D, et al.
bioRxiv
. 2021 Aug;
PMID: 34373854
Nucleoside modified mRNA combined with Acuitas Therapeutics' lipid nanoparticles (LNP) have been shown to support robust humoral immune responses in many preclinical animal vaccine studies and later in humans with...
10.
Seidel F, Holtgrewe M, Al-Wakeel-Marquard N, Opgen-Rhein B, Dartsch J, Herbst C, et al.
Circ Genom Precis Med
. 2021 Jul;
14(4):e003250.
PMID: 34213952
Background: Myocarditis is one of the most common causes leading to heart failure in children and a possible genetic background has been postulated. We sought to characterize the clinical and...